EQRx

EQRx’s ambitious plan to sell cheap drugs falls apart after $4.2B deal

EQRx’s ambitious plan to sell cheap drugs falls apart after $4.2B deal

Anika Sharma

EQRx, a biotech company founded with the ambitious mission of developing affordable medicines, recently found itself embroiled in a complex ...

EQRx Buys Revolution Medicines for $2.3B in Low-Cost Drugs Quest

How EQRx’s Cheap Drugs Strategy Led to Revolution Deal

SG Tylor

Source – Revolution Medicines EQRx, which made a bold claim to disrupt the pharmaceutical pricing system in 2020, has now ...